Matches in SemOpenAlex for { <https://semopenalex.org/work/W2414135476> ?p ?o ?g. }
Showing items 1 to 60 of
60
with 100 items per page.
- W2414135476 endingPage "9" @default.
- W2414135476 startingPage "93" @default.
- W2414135476 abstract "A study on the biology of 'panic disorder,' which I have classified under the category of 'anxiety disorder,' made progress recently. In a genetic study, the hereditary of panic disorder was checked by a 'linkage and twins' study, and the anticipation of panic disorder was recognized as being the same as that which is also found in the psychiatric conditions known as schizophrenia and manic depression. A panic disorder patient regards the anxious sign of a model as ruinous, and this weakness in recognition has been duly noted. Therefore, I studied a patient showing a continuance state of 'hyper-sensitivity,' and compared this to a patient showing a 'sleep disorder.' Noradrenaline plays an important role in anxiety as suppression of the locus ceruleus (LN), the major NE-containing nucleus of the noradrenaline nervous system, brings on a calming effect. Yohimbine, however, which is an alpha 2 antagonist, is found to induce panic attacks. The fact that selective serotonin reuptake inhibitor (SSRI) suppresses panic attacks suggests that serotonin is connected with panic disorders. It is also thought that the 'raphe nucleus' is the site of origin of the serotonin nervous system, which participates in the control of anxiety. This suggests the participation of a gamma-aminobutyric acid (GABA) nervous system in which the administration of benzodiazepine at a high potency would be an effective agent against panic disorder. Cholecystokinin (CCK) is also suggested to have a connection with panic disorder as CCK-4 causes panic attacks. There has been no CCK antagonist found effective for an object- or time-oriented panic disorder at the present. It is thought that corticotropin-releasing factor (CRF) is released during a panic attack. The development of a new CRF receptor antagonist is needed. In addition to the studies on the neurotransmitters of the traditional type, such as noradrenaline, serotonin and GABA, studies on the neuropeptides, such as CCK and CRF have become important for future consideration. Understanding this, image studies such as MRI, SPECT, fMRI and PET have become highly desirable." @default.
- W2414135476 created "2016-06-24" @default.
- W2414135476 creator A5068487342 @default.
- W2414135476 date "1999-07-01" @default.
- W2414135476 modified "2023-09-23" @default.
- W2414135476 title "[Neuropharmacological and genetic study of panic disorder]." @default.
- W2414135476 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10495983" @default.
- W2414135476 hasPublicationYear "1999" @default.
- W2414135476 type Work @default.
- W2414135476 sameAs 2414135476 @default.
- W2414135476 citedByCount "7" @default.
- W2414135476 countsByYear W24141354762014 @default.
- W2414135476 countsByYear W24141354762015 @default.
- W2414135476 countsByYear W24141354762016 @default.
- W2414135476 countsByYear W24141354762017 @default.
- W2414135476 crossrefType "journal-article" @default.
- W2414135476 hasAuthorship W2414135476A5068487342 @default.
- W2414135476 hasConcept C118552586 @default.
- W2414135476 hasConcept C137183658 @default.
- W2414135476 hasConcept C15744967 @default.
- W2414135476 hasConcept C169760540 @default.
- W2414135476 hasConcept C2776317618 @default.
- W2414135476 hasConcept C2777529043 @default.
- W2414135476 hasConcept C2780712732 @default.
- W2414135476 hasConcept C2780938664 @default.
- W2414135476 hasConcept C2909480419 @default.
- W2414135476 hasConcept C513476851 @default.
- W2414135476 hasConcept C558461103 @default.
- W2414135476 hasConceptScore W2414135476C118552586 @default.
- W2414135476 hasConceptScore W2414135476C137183658 @default.
- W2414135476 hasConceptScore W2414135476C15744967 @default.
- W2414135476 hasConceptScore W2414135476C169760540 @default.
- W2414135476 hasConceptScore W2414135476C2776317618 @default.
- W2414135476 hasConceptScore W2414135476C2777529043 @default.
- W2414135476 hasConceptScore W2414135476C2780712732 @default.
- W2414135476 hasConceptScore W2414135476C2780938664 @default.
- W2414135476 hasConceptScore W2414135476C2909480419 @default.
- W2414135476 hasConceptScore W2414135476C513476851 @default.
- W2414135476 hasConceptScore W2414135476C558461103 @default.
- W2414135476 hasIssue "3" @default.
- W2414135476 hasLocation W24141354761 @default.
- W2414135476 hasOpenAccess W2414135476 @default.
- W2414135476 hasPrimaryLocation W24141354761 @default.
- W2414135476 hasRelatedWork W121796335 @default.
- W2414135476 hasRelatedWork W1984377422 @default.
- W2414135476 hasRelatedWork W2007784132 @default.
- W2414135476 hasRelatedWork W2049172162 @default.
- W2414135476 hasRelatedWork W2072508645 @default.
- W2414135476 hasRelatedWork W2091004398 @default.
- W2414135476 hasRelatedWork W2109158525 @default.
- W2414135476 hasRelatedWork W2158415380 @default.
- W2414135476 hasRelatedWork W2255227742 @default.
- W2414135476 hasRelatedWork W3022256442 @default.
- W2414135476 hasVolume "19" @default.
- W2414135476 isParatext "false" @default.
- W2414135476 isRetracted "false" @default.
- W2414135476 magId "2414135476" @default.
- W2414135476 workType "article" @default.